Over a year after the World Health Organization declared the COVID-19 to be a global pandemic, the US should be leading global diagnostic efforts for COVID-19; instead, we have lagged in our response to dangerous viral mutations and variants. The US is home to many of the world’s leading clinical laboratories, test manufacturers, and most prominent thought leaders, but we have trailed many developed countries in ramping up diagnosis and characterization of SARS-CoV-2.
